NO20044091L - Anvendelse av substituerte 3-fenyl-5-alkoksy-1,3,4-oksdiazol-2-on for fremstilling av medikamenter som inhiberer pankreatisk lipase - Google Patents
Anvendelse av substituerte 3-fenyl-5-alkoksy-1,3,4-oksdiazol-2-on for fremstilling av medikamenter som inhiberer pankreatisk lipaseInfo
- Publication number
- NO20044091L NO20044091L NO20044091A NO20044091A NO20044091L NO 20044091 L NO20044091 L NO 20044091L NO 20044091 A NO20044091 A NO 20044091A NO 20044091 A NO20044091 A NO 20044091A NO 20044091 L NO20044091 L NO 20044091L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- oxdiazol
- alkoxy
- phenyl
- substituted
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 3
- 102000019280 Pancreatic lipases Human genes 0.000 title abstract 2
- 108050006759 Pancreatic lipases Proteins 0.000 title abstract 2
- 229940116369 pancreatic lipase Drugs 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 4
- 239000002253 acid Substances 0.000 abstract 2
- 208000008589 Obesity Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Child & Adolescent Psychology (AREA)
- Nutrition Science (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10208986A DE10208986A1 (de) | 2002-02-28 | 2002-02-28 | Verwendung substituierter 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one zur Herstellung von Arzneimitteln mit hemmender Wirkung an der pankreatischen Lipase |
| PCT/EP2003/001560 WO2003072098A1 (de) | 2002-02-28 | 2003-02-17 | Verwendung substituierter 3-phenyl-5-alkoxy-1,3,4-oxdiazol-2-one zur herstellung von arzneimitteln mit hemmender wirkung an der pankreatischen lipase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20044091L true NO20044091L (no) | 2004-09-27 |
Family
ID=27740557
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20044091A NO20044091L (no) | 2002-02-28 | 2004-09-27 | Anvendelse av substituerte 3-fenyl-5-alkoksy-1,3,4-oksdiazol-2-on for fremstilling av medikamenter som inhiberer pankreatisk lipase |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1482929A1 (pl) |
| JP (1) | JP2005519079A (pl) |
| KR (1) | KR20040101250A (pl) |
| CN (1) | CN1638766A (pl) |
| AR (1) | AR038702A1 (pl) |
| AU (1) | AU2003210292A1 (pl) |
| BR (1) | BR0308045A (pl) |
| CA (1) | CA2477005A1 (pl) |
| CO (1) | CO5611144A2 (pl) |
| DE (1) | DE10208986A1 (pl) |
| HR (1) | HRP20040783A2 (pl) |
| HU (1) | HUP0500093A2 (pl) |
| IL (1) | IL163719A0 (pl) |
| MA (1) | MA27173A1 (pl) |
| MX (1) | MXPA04007480A (pl) |
| NO (1) | NO20044091L (pl) |
| PL (1) | PL371310A1 (pl) |
| RU (1) | RU2004128932A (pl) |
| TW (1) | TW200400026A (pl) |
| WO (1) | WO2003072098A1 (pl) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5080970B2 (ja) | 2004-06-17 | 2012-11-21 | サイトキネティクス・インコーポレーテッド | 心疾患を治療するための置換尿素誘導体 |
| AU2005298692A1 (en) | 2004-10-25 | 2006-05-04 | Solvay Pharmaceuticals Gmbh | Pharmaceutical compositions comprising CB1 cannabinoid receptor antagonists and potassium channel openers for the treatment of diabetes mellitus type I, obesity and related conditions |
| TW200808321A (en) | 2005-12-15 | 2008-02-16 | Cytokinetics Inc | Certain chemical entities, compositions and methods |
| US7825120B2 (en) | 2005-12-15 | 2010-11-02 | Cytokinetics, Inc. | Certain substituted ((piperazin-1-ylmethyl)benzyl)ureas |
| EP1962852B1 (en) | 2005-12-19 | 2017-01-25 | Cytokinetics, Inc. | Compounds, compositions and methods |
| CA2708447C (en) * | 2007-12-25 | 2016-05-10 | Kissei Pharmaceutical Co., Ltd. | Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition |
| AR074978A1 (es) | 2008-12-23 | 2011-03-02 | Bial Portela & Ca Sa | 3-n-aril-1,3,4-oxadiazolonas 5-o-sustituidas para uso en el tratamiento del dolor y procedimiento de obtencion |
| CN103086859B (zh) * | 2011-11-08 | 2015-11-11 | 清华大学 | 2,4-二羟基-5,6-取代-1-卤代苯衍生物、其合成方法及其应用 |
| CN111527065B (zh) * | 2017-09-01 | 2024-05-07 | 科廷大学 | 油酰基-溶血磷脂酰肌醇(油酰基-lpi)的合成衍生物及其用途 |
| CN109879839B (zh) * | 2019-03-12 | 2023-04-25 | 沈阳大学 | 6-哌嗪甲基-7-羟基苯并呋喃类化合物及其医药用途 |
| PH12022552021A1 (en) * | 2020-02-07 | 2024-02-05 | Cytokinetics Inc | Nampt modulators |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19942354A1 (de) * | 1999-09-04 | 2001-03-08 | Aventis Pharma Gmbh | Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, ihre Herstellung und Verwendung in Arzneimitteln |
| RU2281283C2 (ru) * | 2000-03-07 | 2006-08-10 | Санофи-Авентис Дойчланд Гмбх | Замещенные 3-фенил-5-алкокси-1,3,4-оксадиазол-2-оны и их применение для ингибирования гормоночувствительной липазы |
-
2002
- 2002-02-28 DE DE10208986A patent/DE10208986A1/de not_active Withdrawn
-
2003
- 2003-02-17 MX MXPA04007480A patent/MXPA04007480A/es unknown
- 2003-02-17 CA CA002477005A patent/CA2477005A1/en not_active Abandoned
- 2003-02-17 KR KR10-2004-7013470A patent/KR20040101250A/ko not_active Withdrawn
- 2003-02-17 AU AU2003210292A patent/AU2003210292A1/en not_active Abandoned
- 2003-02-17 BR BR0308045-5A patent/BR0308045A/pt not_active Application Discontinuation
- 2003-02-17 EP EP03742942A patent/EP1482929A1/de not_active Withdrawn
- 2003-02-17 CN CNA038047675A patent/CN1638766A/zh active Pending
- 2003-02-17 RU RU2004128932/15A patent/RU2004128932A/ru not_active Application Discontinuation
- 2003-02-17 JP JP2003570844A patent/JP2005519079A/ja not_active Withdrawn
- 2003-02-17 IL IL16371903A patent/IL163719A0/xx unknown
- 2003-02-17 HR HR20040783A patent/HRP20040783A2/hr not_active Application Discontinuation
- 2003-02-17 PL PL03371310A patent/PL371310A1/pl not_active Application Discontinuation
- 2003-02-17 HU HU0500093A patent/HUP0500093A2/hu unknown
- 2003-02-17 WO PCT/EP2003/001560 patent/WO2003072098A1/de not_active Ceased
- 2003-02-26 TW TW092103972A patent/TW200400026A/zh unknown
- 2003-02-26 AR ARP030100625A patent/AR038702A1/es unknown
-
2004
- 2004-07-27 MA MA27804A patent/MA27173A1/fr unknown
- 2004-08-26 CO CO04083781A patent/CO5611144A2/es not_active Application Discontinuation
- 2004-09-27 NO NO20044091A patent/NO20044091L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CO5611144A2 (es) | 2006-02-28 |
| BR0308045A (pt) | 2004-12-21 |
| EP1482929A1 (de) | 2004-12-08 |
| IL163719A0 (en) | 2005-12-18 |
| CA2477005A1 (en) | 2003-09-04 |
| HUP0500093A2 (hu) | 2005-04-28 |
| RU2004128932A (ru) | 2005-04-10 |
| AU2003210292A1 (en) | 2003-09-09 |
| WO2003072098A1 (de) | 2003-09-04 |
| CN1638766A (zh) | 2005-07-13 |
| PL371310A1 (pl) | 2005-06-13 |
| DE10208986A1 (de) | 2003-09-11 |
| TW200400026A (en) | 2004-01-01 |
| AR038702A1 (es) | 2005-01-26 |
| HRP20040783A2 (en) | 2005-04-30 |
| MA27173A1 (fr) | 2005-01-03 |
| JP2005519079A (ja) | 2005-06-30 |
| MXPA04007480A (es) | 2004-11-10 |
| KR20040101250A (ko) | 2004-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20072542L (no) | Pyrimidinderivat kondensert med ikke-aromatisk ring | |
| NO20055680L (no) | Heksahydropyridoisokinoliner som DPP-IV-inhibitorer | |
| TWI255817B (en) | Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof | |
| NO20082643L (no) | Isokinolinaminopyrazolderivater, deres fremstilling og anvendelse som farmasoytiske midler for behandling av kreft | |
| NO20060908L (no) | Substituerte tazol-benzoisotiazoldioksidderivater, deres fremstilling og anvendelse | |
| NO20050648L (no) | Heterocyklisk substituerte benzoylureaer, fremgangsmate for fremstilling derav og deres anvendelse som medikamenter | |
| NO20073831L (no) | Medikamenter for behandling eller forebygging av fibrotiske sykdommer | |
| NO20062691L (no) | Azabicykliske heterocykler som cannabinoide reseptormodulatorer | |
| NO20051871L (no) | Opioidreseptorantagonister | |
| NO20052883L (no) | Nye medikamenter for behandling av kronisk obstruktiv luftveissykdom. | |
| WO2003063864A3 (fr) | Composes heterocycliques, actifs comme inhibiteurs de beta-lactamases | |
| WO2005082414A3 (en) | Concomitant drugs of a sulfonamide and another therapeutic agent | |
| NO20055887L (no) | Pyrido'2, 1-A-isokinoliderivater som DPP-IV-inhibitorer | |
| WO2007060140A3 (en) | Inhibitors of diacyglycerol acyltransferase (dgat) | |
| SE0202462D0 (sv) | Novel use | |
| WO2005044192A3 (en) | Triazole compounds and uses related thereto | |
| NO20052914L (no) | Terapeutiske forbindelser | |
| IL165264A (en) | Protein kinase inhibitors, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for treating protein kinase-associated diseases | |
| NO20051709L (no) | Kystallforbindelse for fast oralt medikament samt fast oralt medikament omfattende denne til behandling av dysuria | |
| TW200736223A (en) | N-(pyridin-2-yl)-sulfonamide derivatives | |
| NO20065904L (no) | Terapeutiske forbindelser | |
| SE0202429D0 (sv) | Novel Compounds | |
| NO20054868L (no) | CaSr antagonist | |
| GB0222514D0 (en) | Organic compounds | |
| NO20073830L (no) | Medikamenter for behandling eller forebygging av fibrotiske sykdommer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |